CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flows from operating activities:
Net income (loss)	$ (249,064)	$ (434,427)
Adjustments to net income (loss):
Depreciation and amortization	496,231	525,427
Deferred income tax expense (benefit)	4,712	(9,305)
Impairments and other charges		72,898
Amortization of debt discount and deferred financing costs	8,012	15,846
Losses (gains) on debt buyback	(1,636)	(10,706)
Losses (gains) on long-lived assets, net	1,130	17,299
Losses (gains) on investments, net	544	(767)
Provision (recovery) of bad debt		(350)
Share-based compensation	11,854	15,207
Foreign currency transaction losses (gains), net	(4,054)	3,391
Mark-to-market loss on warrants	59,717
Noncontrolling interest	(32,132)	(21,168)
Other	176	737
Changes in operating assets and liabilities, net of effects from acquisitions:
Accounts receivable	(29,828)	74,873
Inventory	(312)	21,137
Other current assets	(12,578)	(6,060)
Other long-term assets	(12,301)	3,721
Trade accounts payable and accrued liabilities	30,538	8,485
Income taxes payable	(66)	12,622
Other long-term liabilities	30,157	37,623
Net cash provided by (used for) operating activities	301,100	326,483
Cash flows from investing activities:
Purchases of investments	(19,000)	(14,041)
Sales and maturities of investments	21	11,371
Purchase of intangible assets		(3,600)
Capital expenditures	(272,080)	(179,902)
Proceeds from sales of assets	24,030	121,678
Other	27	(594)
Net cash (used for) provided by investing activities	(267,002)	(65,088)
Cash flows from financing activities:
Reduction in long-term debt	(133,853)	(151,508)
Debt issuance costs	(3,864)	(2,421)
Proceeds from revolving credit facilities	250,000	565,000
Reduction in revolving credit facilities	(710,000)	(312,500)
Proceeds from issuance of common shares, net of issuance costs	3,767
Repurchase of common and preferred shares	(4,523)
Dividends to common and preferred shareholders	(65)	(7,380)
Redeemable noncontrolling interest distribution		(49,077)
Distributions to noncontrolling interest	(3,489)	(1,790)
Other	(445)	(2,496)
Net cash (used for) provided by financing activities	(602,472)	37,828
Effect of exchange rate changes on cash and cash equivalents	(863)	(720)
Net increase (decrease) in cash and cash equivalents and restricted cash	(569,237)	298,503
Cash and cash equivalents and restricted cash, beginning of period	1,273,510	475,280
Cash and cash equivalents and restricted cash, end of period	704,273	773,783
RECONCILIATION OF CASH AND CASH EQUIVALENTS AND RESTRICTED CASH
Cash and cash equivalents, beginning of period	991,471	472,246
Restricted cash, beginning of period	282,039	3,034
Cash and cash equivalents and restricted cash, beginning of period	1,273,510	475,280
Cash and cash equivalents, end of period	420,307	771,878
Restricted cash, end of period	$ 283,966	$ 1,905
Restricted cash, Balance Sheet location	Restricted cash held in trust	Restricted cash held in trust
Cash and cash equivalents and restricted cash, end of period	$ 704,273	$ 773,783